Photo by sharonmccutcheon from unsplash
Key Points Given high relapse and CNS involvement of BPDCN, combination chemotherapy and prophylactic CNS-directed therapy are urgently needed. HCVAD chemotherapy plays an important role in the treatment of BPDCN,… Click to show full abstract
Key Points Given high relapse and CNS involvement of BPDCN, combination chemotherapy and prophylactic CNS-directed therapy are urgently needed. HCVAD chemotherapy plays an important role in the treatment of BPDCN, even in the modern era of CD123-targeted therapy.
Keywords:
outcomes patients;
characteristics outcomes;
hcvad;
plasmacytoid dendritic;
patients blastic;
blastic plasmacytoid
Journal Title: Blood Advances
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Blood Advances
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!